Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2010
12/15/2010CN101914150A Polypeptide and use thereof in medicament preparation
12/15/2010CN101914092A Azabicyclo alkane derivative and preparation method and application thereof in medicaments
12/15/2010CN101913583A Method for extracting chondroitin, collagen and high-calcium powder from animal cartilage
12/15/2010CN101912617A Application of MG53 gene to treatment of insulin resistance, type II diabetes mellitus and related diseases thereof
12/15/2010CN101912612A Dispersible tablet containing fibrate and statin drug and application thereof
12/15/2010CN101912600A Method for improving stability of insulin in solution
12/15/2010CN101912565A Turmeric and astragalus capsules for treating diabetes and incipient diabetic nephropathy
12/15/2010CN101912491A Pills for treating cardiovascular diseases and preparation method
12/15/2010CN101912489A Medicament for treating obesity
12/15/2010CN101912484A Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia
12/15/2010CN101912470A Chinese medicinal powder for treating diabetes
12/15/2010CN101912446A Application of forsythia chloroform extracts to preparing medicine for treating diabetes mellitus
12/15/2010CN101912445A Method for extracting general flavonoids from toona sinensis leaves under assistance of surfactant
12/15/2010CN101912436A Ultrasonic extraction method of alfalfa saponin
12/15/2010CN101912435A Manyflower tickclover herbal extract and application thereof
12/15/2010CN101912429A New technology combining reversed micelle and ultrasonic high-efficiency extraction for extracting total saponin of Aralia taibaiensis
12/15/2010CN101912424A Preparation method of red yeast rice containing Bacillus natto
12/15/2010CN101912423A Method for manufacturing Monascus products containing probiotics
12/15/2010CN101912418A Instant donkey-hide gelatin powder and preparation method thereof
12/15/2010CN101912417A Instant donkey-hide gelatin granules and preparation method thereof
12/15/2010CN101912408A Application of alginate sulfuric ester in preparing drugs for preventing and treating diabetes and vascular diseases
12/15/2010CN101912407A Weight-reducing and lipid-lowering composition
12/15/2010CN101912404A Small-capacity injection containing four vitamins and preparation method thereof
12/15/2010CN101912392A Pharmaceutical compositions comprising colloidal silicon dioxide
12/15/2010CN101912388A Method for preparing medium-chain fatty acid-vitamin C liposome through inverted evaporation-high pressure micro jet
12/15/2010CN101912380A Compounds for the treatment of metabolic disorders
12/15/2010CN101912375A Metformin controlled release tablet
12/15/2010CN101912371A Coenzyme Q10-containing injection composition and preparation method thereof
12/15/2010CN101912352A Agent for promoting vitamin c transporter production
12/15/2010CN101632634B N(2)-L-alanyl-L-glutamine liposome injection and preparation method thereof
12/15/2010CN101584704B Medicinal application of medicinal salt or derivative of heparin and low molecular heparin
12/15/2010CN101554445B Traditional Chinese medicine for treating diabetic hyperlipemia
12/15/2010CN101554436B Traditional Chinese medicine for treating diabetic stubborn insomnia
12/15/2010CN101530593B Traditional Chinese medicine for treating diabetic numbness of extremities
12/15/2010CN101439031B Pharmaceutical composition containing 18 kinds of amino acid
12/15/2010CN101385731B Osmotic pump controlled release preparation composition for treating hyperlipemia and preparation method thereof
12/15/2010CN101342186B Use of pentacyclic triterpene saponin compound
12/15/2010CN101341943B Corn high-strength flour, corn slimming noodle and preparing method
12/15/2010CN101249190B Anti-inflammation sterilizing Chinese medicine compound externally used coating liquid and method of preparing the same
12/15/2010CN101233885B Health tea
12/15/2010CN101181306B Nano-scale compound pearl dimension C lozenge and preparation method thereof
12/15/2010CN101076323B Medicine composition for treating fatmass
12/15/2010CN101007017B Extract of traditional Chinese medicine having alpha-glucosidase inhibitor activity and its application
12/15/2010CN101003574B Recombined expression of peptide for lowering blood sugar in long acting, and application in medication for treating diabetes
12/15/2010CN100999517B Pyrazole formylamine derivate, its pharmaceutical composition and preparation process
12/14/2010US7851622 6-(4-Chlorophenyl)-3-(4-(2-hydroxy-2-methylpropoxy)-3-methoxyphenyl)-thieno[3,2-d][1,2,3]triazin-4(3H)-one, for example; for treating a patient suffering from an MCHR-1 modulated disease or disorder such as obesity, diabetes, depression or anxiety
12/14/2010US7851589 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage
12/14/2010US7851507 Administering to a lung cancer patient 2-hydroxyoleic acid in an amount effective to inhabit proliferation of the cancer; leukemia, brain metastasis
12/14/2010US7851502 Pharmaceutical formulations containing an SGLT2 inhibitor
12/14/2010US7851494 administering 5-[(4-(2,6-difluorobenzyloxy)phenyl)-methyl]-1H-tetrazole for the treatment of insulin resistance, diabetes, hyperlipemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
12/14/2010US7851450 Gangliosides with a modified acyl function
12/14/2010US7851171 Using actinobacillus specific immunogolbulins to diagnose gum disease
12/14/2010US7851164 Using zinc transporter protein-8 to identify modulators for treatment and diagnosis of diabetic disorders
12/14/2010US7850991 Calcium formate for use as a dietary supplement
12/14/2010US7850976 Insulin resistance improving agents
12/14/2010US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders
12/14/2010US7850963 Vascular endothelial growth factor 2
12/14/2010CA2485641C Novel condensed imidazole derivatives
12/14/2010CA2470044C Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
12/14/2010CA2458524C C2-disubstituted indane-1-ones and their derivatives, method for their production and their use as medicaments
12/14/2010CA2458520C Polysubstituted indan-1-ol systems, method for the production and use thereof as drugs
12/14/2010CA2446673C Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2417484C Elongase genes and uses thereof
12/14/2010CA2412723C Benzothiazolyl ppar-gamma modulators
12/14/2010CA2373433C Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
12/14/2010CA2366857C Phthalazine derivatives for treating inflammatory diseases
12/14/2010CA2336781C Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics
12/14/2010CA2159546C Cycloalkano-indole and -azaindole derivatives
12/09/2010WO2010141810A2 Compositions and methods modulating mg29 for the treatment of diabetes
12/09/2010WO2010141771A1 Nucleic acid modulators of glycoprotein vi
12/09/2010WO2010141424A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/09/2010WO2010141074A2 O-glcnac transferase inhibitors and uses thereof
12/09/2010WO2010140765A2 Novel method for preparing rosuvastatin, intermediate compounds useful for preparing same, and method for preparing same
12/09/2010WO2010140685A1 Heterocyclic compound and hematopoietic stem cell amplifier
12/09/2010WO2010140531A1 Pharmaceutical composition, food or beverage, and methods for these products
12/09/2010WO2010140435A1 Β-galactosidase derived from bacillus circulans
12/09/2010WO2010140401A1 Microneedle array using porous substrate and process for producing same
12/09/2010WO2010140165A1 A novel antidiabetic furostanolic saponin rich (fsr) fraction from fenugreek seeds
12/09/2010WO2010140092A1 L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
12/09/2010WO2010139678A1 Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms
12/09/2010WO2010139180A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010WO2010102402A3 Compositions and methods for management of peripheral arterial disease
12/09/2010WO2010100060A3 Method for increasing endogenous plasmalogen levels in mammals
12/09/2010WO2010090423A3 Composition comprising combined crude drug extract for preventing and treating hyperlipidemia and diabetic hyperlipidemia
12/09/2010US20100313285 Altering High Density Lipoprotein Levels Through UDP-N-Acetyl-Alpha-D-Galactosamine: Polypeptide N-Acetlgalactosaminyltransferase (GALNT) Modulation
12/09/2010US20100312312 Method for selective photodynamic therapy and light source for implementation thereof
12/09/2010US20100311837 Method for improving storage stability of glutathione
12/09/2010US20100311834 Methods of treating hypertriglyceridemia
12/09/2010US20100311828 Extracts of sclerocarya birrea
12/09/2010US20100311820 Nucleic acid modulators of glycoprotein vi
12/09/2010US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/09/2010US20100311807 Methods for identifying diabetes and obesity therapeutics
12/09/2010US20100311802 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
12/09/2010US20100311795 1,3-dioxane carboxylic acids
12/09/2010US20100311787 Compounds for inflammation and immune-related uses
12/09/2010US20100311778 Chromane derivatives as trpv3 modulators
12/09/2010US20100311776 Novel sEH Inhibitors and their Use
12/09/2010US20100311775 Novel sEH Inhibitors and Their Use
12/09/2010US20100311767 Method for the treatment of amyloidoses